Hæmatologiske anormaliteter Der forekom fald i neutrofiltal til under 1 x 109/ l hos 3, 4% af de patienter, som fik tocilizumab 8 mg/ kg plus DMARDs, sammenlignet med < 0, 1% af de patienter, som fik placebo plus DMARDs.
Haematological abnormalities Decreases in neutrophil counts below 1 x 109/ l occurred in 3.4% of patients on tocilizumab 8 mg/ kg plus DMARDs compared to < 0.1% of patients on placebo plus DMARDs.